FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

425913002: Methoxy polyethylene glycol-epoetin beta (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2007. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2661643013 Methoxy polyethylene glycol-epoetin beta (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2675373018 Methoxy polyethylene glycol-epoetin beta en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
60141000195116 metossipolietilenglicole-epoetina beta it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
31491000188112 méthoxy polyéthylène glycol-époétine bêta fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
824711000172111 methoxy-polyéthylenglycol-époétin beta fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
1119581000241118 époétine bêta pégylée fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
235721000195118 PEG - Methoxy-Polyethylenglycol-Epoetin beta de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
236881000195117 Methoxy-Polyethylenglycol-Epoetin beta de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Methoxy polyethylene glycol-epoetin beta (substance) Is a Epoetin beta (substance) false Inferred relationship Some
Methoxy polyethylene glycol-epoetin beta (substance) Is a Substance with continuous erythropoietin receptor activator mechanism of action false Inferred relationship Some
Methoxy polyethylene glycol-epoetin beta (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Continuous erythropoietin receptor activator false Inferred relationship Some
Methoxy polyethylene glycol-epoetin beta (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Epoetin beta (substance) true Inferred relationship Some
Methoxy polyethylene glycol-epoetin beta (substance) Is a Erythropoietin false Inferred relationship Some
Methoxy polyethylene glycol-epoetin beta (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Renal hormone (disposition) false Inferred relationship Some
Methoxy polyethylene glycol-epoetin beta (substance) Is a Erythropoietin receptor agonist true Inferred relationship Some
Methoxy polyethylene glycol-epoetin beta (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Erythropoietin receptor agonist (disposition) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing methoxy polyethylene glycol-epoetin beta (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some
Methoxy polyethylene glycol-epoetin beta 200micrograms/mL injection solution 1mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some
Methoxy polyethylene glycol-epoetin beta 100micrograms/mL injection solution 1mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some
Methoxy polyethylene glycol-epoetin beta 50micrograms/mL injection solution 1mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some
Methoxy polyethylene glycol-epoetin beta 75micrograms injection solution 0.3mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some
Methoxy polyethylene glycol-epoetin beta 250micrograms injection solution 0.3mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some
Methoxy polyethylene glycol-epoetin beta 800micrograms injection solution 0.6mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some
Methoxy polyethylene glycol-epoetin beta 400micrograms injection solution 0.6mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some
Methoxy polyethylene glycol-epoetin beta 600micrograms injection solution 0.6mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some
Methoxy polyethylene glycol-epoetin beta 300micrograms/mL injection solution 1mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some
Methoxy polyethylene glycol-epoetin beta 200micrograms injection solution 0.3mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some
Methoxy polyethylene glycol-epoetin beta 50micrograms injection solution 0.3mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some
Methoxy polyethylene glycol-epoetin beta 150micrograms injection solution 0.3mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some
Methoxy polyethylene glycol-epoetin beta 1000micrograms/mL injection solution 1mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some
Methoxy polyethylene glycol-epoetin beta 400micrograms/mL injection solution 1mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some
Methoxy polyethylene glycol-epoetin beta 600micrograms/mL injection solution 1mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some
Product containing precisely methoxy polyethylene glycol-epoetin beta 150 microgram/0.3 milliliter conventional release solution for injection syringe This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some 1
Product containing precisely methoxy polyethylene glycol-epoetin beta 150 microgram/0.3 milliliter conventional release solution for injection syringe The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some 1
Product containing precisely methoxy polyethylene glycol-epoetin beta 200 microgram/0.3 milliliter conventional release solution for injection syringe The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some 1
Product containing precisely methoxy polyethylene glycol-epoetin beta 200 microgram/0.3 milliliter conventional release solution for injection syringe This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some 1
Product containing precisely methoxy polyethylene glycol-epoetin beta 250 microgram/0.3 milliliter conventional release solution for injection syringe The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some 1
Product containing precisely methoxy polyethylene glycol-epoetin beta 250 microgram/0.3 milliliter conventional release solution for injection syringe This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some 1
Product containing precisely methoxy polyethylene glycol-epoetin beta 50 microgram/0.3 milliliter conventional release solution for injection syringe This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some 1
Product containing precisely methoxy polyethylene glycol-epoetin beta 50 microgram/0.3 milliliter conventional release solution for injection syringe The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some 1
Product containing precisely methoxy polyethylene glycol-epoetin beta 75 microgram/0.3 milliliter conventional release solution for injection syringe The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some 1
Product containing precisely methoxy polyethylene glycol-epoetin beta 75 microgram/0.3 milliliter conventional release solution for injection syringe This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some 1
Methoxy polyethylene glycol-epoetin beta 250 microgram/mL solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some 1
Methoxy polyethylene glycol-epoetin beta 250 microgram/mL solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some 1
Methoxy polyethylene glycol-epoetin beta 666.667 microgram/mL solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some 1
Methoxy polyethylene glycol-epoetin beta 666.667 microgram/mL solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some 1
Methoxy polyethylene glycol-epoetin beta 500 microgram/mL solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some 1
Methoxy polyethylene glycol-epoetin beta 500 microgram/mL solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some 1
Methoxy polyethylene glycol-epoetin beta 166.667 microgram/mL solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some 1
Methoxy polyethylene glycol-epoetin beta 166.667 microgram/mL solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some 1
Product containing precisely methoxy polyethylene glycol-epoetin beta 833.333 microgram/1 milliliter conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some 1
Product containing precisely methoxy polyethylene glycol-epoetin beta 833.333 microgram/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some 1
Product containing methoxy polyethylene glycol-epoetin beta (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some 1
Methoxy polyethylene glycol-epoetin beta only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some 1
Product containing only methoxy polyethylene glycol-epoetin beta in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some 1
Product containing methoxy polyethylene glycol-epoetin beta in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Methoxy polyethylene glycol-epoetin beta (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start